Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Endoscopy|February 1, 1993
Influence of tumor stenosis on the accuracy of endosonography in preoperative T staging of esophageal cancerM L Hordijk, H Zander, M van Blankenstein, et al.
Tissue Antigens|April 1, 1979
HLA-A, -B, and -D antigens in paralytic poliomyelitisH Zander, H Grosse-Wilde, B Kuntz, et al.
AANA Journal|September 29, 2020
Postpoliomyelitis Syndrome and Reversal With Sugammadex: A Case ReportVictoria E Marshall, Jessica S Storey, Beth A Clayton, et al.
Human Immunology|May 1, 1983
Genetic influence on natural cytotoxicity and interferon production in multiple sclerosis studies in monozygotic discordant twinsP Kaudewitz, H Zander, J Abb, et al.
Cytogenetics and Cell Genetics|January 1, 1993
The human endothelin-1 gene (EDN1) encoding a peptide with potent vasoactive properties maps distal to HLA on chromosome arm 6p in close linkage to D6S89M R Hoehe, H Ehrenreich, B Otterud, et al.
ESMO Open|May 3, 2021
The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancerA Trullas, J Delgado, A Genazzani, et al.
The EMBO Journal|April 15, 1999
Characterization of GAPCenA, a GTPase activating protein for Rab6, part of which associates with the centrosomeM H Cuif, F Possmayer, H Zander, et al.
ESMO Open|June 1, 2022
The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancerS Michaleas, A Moreno Oliver, J Mueller-Berghaus, et al.
ESMO Open|January 5, 2021
The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitorsI Araujo-Fernandez, J Delgado, L Moscetti, et al.
Pageof 2